top of page
Search

Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study

COSSAP

Recent policies have lessened restrictions around prescribing buprenorphine-naloxone (buprenorphine) for the treatment of opioid use disorder (OUD). The primary concern expressed by critics of these policies is the potential for buprenorphine diversion. However, the population-level effects of increased buprenorphine diversion are unclear. If replacing the use of heroin or fentanyl, use of diverted buprenorphine could be protective.


0 comments

Comentários


bottom of page